Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The Globe and Mail
45m
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to treat type 2 diabetes. Novo's drugs Ozempic and Wegovy are household names ...
The Globe and Mail
45m
Is Viking Therapeutics a Buy on the Dip?
You'll probably recognize their names after seeing them in the news or across social media: Ozempic and Wegovy (made by Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Trump sweeps swing states
Delaney wins US House seat
US woman killed in Hungary
Resigns after election losses
Judith Jamison dies
Man charged with arson
NASCAR legend Allison dies
FTX sues Scaramucci
Philippines new maritime laws
Gabriel breaks NCAA record
Ranger dies in wildfire
UKR drones strike Moscow
Rockefeller tree arrives
Wins Nevada Senate race
‘Candyman' star dies
Qatar halts Gaza mediation
Asked to be US trade chief
Global food prices rise
Suit over Philly ballots
Seattle stabbing spree ends
IL weapons ban blocked
Gauff wins WTA Finals
US energy revenue 2024
Launches bid to chair NRSC
Consumer sentiment rises
Ex-Blazers broadcaster dies
Leads Grammy nominations
Wins 1st NASCAR Xfinity title
S&P 500 breaks 6,000 level
UN nuclear head to visit Iran
Hits $80K for the first time
US military targets Houthis
Related topics
United States
Ozempic
semaglutide
Ascendis Pharma
Feedback